Quarterly report pursuant to Section 13 or 15(d)

Temporary Equity and Stockholders' Deficiency - Schedule of Share-based Compensation, Equity Instruments Other Than Options, by Exercise Price Range (Details)

v3.19.3
Temporary Equity and Stockholders' Deficiency - Schedule of Share-based Compensation, Equity Instruments Other Than Options, by Exercise Price Range (Details)
9 Months Ended
Sep. 30, 2019
$ / shares
shares
Warrants [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Warrants Outstanding, Number of Warrants 627,404
Warrants Exercisable, Number of Warrants 627,404
Range of Exercise Price 2.00 [Member] | Common Stock [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Warrants Outstanding, Exercise Price | $ / shares $ 2.00
Warrants Outstanding Exercisable, Description Common Stock
Warrants Outstanding, Number of Warrants 479,651
Warrants Exercisable, Weighted Average Remaining Life in Years 1 year 4 months 24 days
Warrants Exercisable, Number of Warrants 479,651
Range of Exercise Price 2.30 [Member] | Common Stock [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Warrants Outstanding, Exercise Price | $ / shares $ 2.30
Warrants Outstanding Exercisable, Description Common Stock
Warrants Outstanding, Number of Warrants 21,462
Warrants Exercisable, Weighted Average Remaining Life in Years 3 months 19 days
Warrants Exercisable, Number of Warrants 21,462
Range of Exercise Price 2.50 [Member] | Common Stock [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Warrants Outstanding, Exercise Price | $ / shares $ 2.50
Warrants Outstanding Exercisable, Description Common Stock
Warrants Outstanding, Number of Warrants 126,291
Warrants Exercisable, Weighted Average Remaining Life in Years 1 year 6 months
Warrants Exercisable, Number of Warrants 126,291